Table of Contents
International Journal of Photochemistry
Volume 2014 (2014), Article ID 176989, 4 pages
http://dx.doi.org/10.1155/2014/176989
Research Article

Photoinduced Aromatization of Asymmetrically Substituted 1,4-Dihydropyridine Derivative Drug Cilnidipine

Organic Chemistry Section, Department of Chemistry, Uttaranchal University, Dehradun 248001, India

Received 24 July 2014; Accepted 29 September 2014; Published 20 October 2014

Academic Editor: M. El-Khouly

Copyright © 2014 Waseem Ahmad. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Cosa and J. C. Scaiano, “Laser techniques in the study of drug photochemistry,” Photochemistry and Photobiology, vol. 80, no. 2, pp. 159–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Quintero and M. A. Miranda, “Mechanisms of photosensitization induced by drugs: a general survey,” Ars Pharmaceutica, vol. 41, no. 1, pp. 27–46, 2000. View at Google Scholar · View at Scopus
  3. M. H. Kleinman, M. D. Smith, E. Kurali et al., “An evaluation of chemical photoreactivity and the relationship to phototoxicity,” Regulatory Toxicology and Pharmacology, vol. 58, no. 2, pp. 224–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sortino, G. Cosa, and J. C. Scaiano, “pH Effect on the efficiency of the photodeactivation pathways of naphazoline: a combined steady state and time resolved study,” New Journal of Chemistry, vol. 24, no. 3, pp. 159–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Mielcarek, T. Osmałek, and M. Kruszyńska, “Photodegradation products of new dihydropyridine derivatives,” Chromatographia, vol. 69, no. 5-6, pp. 503–506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Fasani, A. Albini, and M. Mella, “Photochemistry of Hantzsch 1,4-dihydropyridines and pyridines,” Tetrahedron, vol. 64, no. 14, pp. 3190–3196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Momeni, T. Sameh, H. Golmohammadi et al., “An efficient oxidation of 1,4-dihydropyridines to pyridines using silver carbonate on silica gel and celite,” Bulletin of the Korean Chemical Society, vol. 27, no. 3, pp. 355–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Cogan and Y. Haas, “Self-sensitized photo-oxidation of para-indenylidene-dihydropyridine derivatives,” Journal of Photochemistry and Photobiology A: Chemistry, vol. 193, no. 1, pp. 25–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Pávez and M. V. Encinas, “Photophysics and photochemical studies of 1,4-dihydropyridine derivatives,” Photochemistry and Photobiology, vol. 83, no. 3, pp. 722–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Hilgeroth and U. Baumeister, “Formation of novel photodimers from 4-Aryl-1, 4-dihydropyridines,” Chemistry, vol. 7, pp. 4599–4603, 2001. View at Google Scholar
  11. Y. Kawabe, H. Nakamura, E. Hino, and S. Suzuki, “Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets,” Journal of Pharmaceutical and Biomedical Analysis, vol. 47, no. 3, pp. 618–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Wang, Q. Liu, B. Chen, L. P. Zhang, C. H. Tung, and L. Z. Wu, “Photooxidation of Hantzsch 1,4-dihydropyridines by molecular oxygen,” Chinese Science Bulletin, vol. 55, no. 25, pp. 2855–2858, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Sakaki, H. Naruse, M. Masai et al., “Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts,” Annals of Nuclear Medicine, vol. 17, no. 4, pp. 321–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Sakata, M. Shirotani, H. Yoshida et al., “Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension,” Hypertension, vol. 33, no. 6, pp. 1447–1452, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Fukumoto, E. Ishimura, K. Motoyama et al., “Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria,” Diabetes Research and Clinical Practice, vol. 97, no. 1, pp. 91–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Fujii, K. Kameyama, M. Hosono, Y. Hayashi, and K. Kitamura, “Effect of cilnidipine, a novel dihydropyridine Ca11-channel antagonist, on N-type Ca11 channel in rat dorsal root ganglion neurons,” Journal of Pharmacology and Experimental Therapeutics, vol. 280, no. 3, pp. 1184–1191, 1997. View at Google Scholar · View at Scopus
  17. X. Zhang, S. Zhai, R. Zhao, J. Ouyang, X. Li, and W. R. G. Baeyens, “Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection,” Analytica Chimica Acta, vol. 600, no. 1-2, pp. 142–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Onoue, N. Igarashi, Y. Yamauchi et al., “In vitro phototoxicity of dihydropyridine derivatives: a photochemical and photobiological study,” European Journal of Pharmaceutical Sciences, vol. 33, no. 3, pp. 262–270, 2008. View at Publisher · View at Google Scholar · View at Scopus